
Solo Peptide · Energy & Performance Track
A short-acting GHRH analog that signals your pituitary to release growth hormone in natural, pulsatile rhythms. Also known as Mod GRF 1-29 in the research literature. Physician-prescribed and compounded in the U.S. by a 503A-licensed pharmacy.
Adults focused on body composition, recovery sleep, and the lean-mass markers that start drifting after 35. Most patients stack it with a GHRP — Ipamorelin is the common partner — so the pituitary gets both the GHRH “release” signal and the GHRP “amplify” signal at once.
CJC-1295 No DAC binds the GHRH receptor in the anterior pituitary and triggers a brief, clean pulse of growth hormone — closer to your body’s natural pattern than long-acting analogs. The short half-life is the feature, not a bug: it preserves the natural feedback rhythm of your endocrine system instead of overriding it.